Clinical Research / Clinical Trial

Enhancing Clinical Research Services in Hong Kong: The Impact of the Great Bay Area Policy and the "1+" Drug Approval Mechanism

Unlike other Asian countries, initiation of Clinical Research is efficient and covered by an established system, aligned with the registration policy and opportunities on Great Bay Area special drug policy and "1+" mechanism for drug approval.

• Great Bay Area (GBA) special drug policy favors registered innovative pharmaceutics to enlist to China without going through routine procedures, i,e, no investments on clinical trials in China.

• "1+" mechanism for drug approval approved in 1Q 2025 further lowered the entrance barrier, only 1 ICH country approval is required + a local clinical trial is needed to get approvals, and critical for KOLs to establish the clinical experience locally.

Clinical Research hong kong

Our leading team has over 20 years in MNC pharmaceutical company and we have 10+ contracted CRA available to help.

We have a well established working relationship with related parties, including KOl, RN, academic universities, key hospitals, ethics committees, etc ….

Clinical Trial Services

• Feasibility Research on your clinical trial protocol

• Identify and liaise the KOLs

• Setup clinical study

• Proceed the clinical trials by our contracted team

• Submit the data through your trained system